BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 12174924)

  • 1. Papillary solid and cystic pancreatic tumor. Genetic prediction factors for malignancy: report of three cases.
    Brozzetti S; French D; Polistena A; Di Marzo L; Pisani T; Marchese R; Mingazzini P; Mascioli G; Vecchione A; Cavallaro A
    Anticancer Res; 2002; 22(4):2341-6. PubMed ID: 12174924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas.
    Yoshizawa K; Nagai H; Sakurai S; Hironaka M; Morinaga S; Saitoh K; Fukayama M
    Virchows Arch; 2002 Nov; 441(5):437-43. PubMed ID: 12447672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
    Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T
    Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K-Ras and microsatellite marker analysis of fine-needle aspirates from intraductal papillary mucinous neoplasms of the pancreas.
    Schoedel KE; Finkelstein SD; Ohori NP
    Diagn Cytopathol; 2006 Sep; 34(9):605-8. PubMed ID: 16900481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma.
    Jassem J; Jassem E; Jakóbkiewicz-Banecka J; Rzyman W; Badzio A; Dziadziuszko R; Kobierska-Gulida G; Szymanowska A; Skrzypski M; Zylicz M
    Cancer; 2004 May; 100(9):1951-60. PubMed ID: 15112277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P53 mutation but not p16/MTS1 mutation occurs in intraductal papillary mucinous tumors of the pancreas.
    Mueller J; Gansauge S; Mattfeldt T
    Hepatogastroenterology; 2003; 50(50):541-4. PubMed ID: 12749268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillary cystic tumors of the pancreas: assessment of malignant potential by analysis of progesterone receptor, flow cytometry, and ras oncogene mutation.
    Lee WY; Tzeng CC; Chen RM; Tsao CJ; Tseng JY; Jin YT
    Anticancer Res; 1997; 17(4A):2587-91. PubMed ID: 9252685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased K-ras mutation and expression of S100A4 and MUC2 protein in the malignant intraductal papillary mucinous tumor of the pancreas.
    Jang JY; Park YC; Song YS; Lee SE; Hwang DW; Lim CS; Lee HE; Kim WH; Kim SW
    J Hepatobiliary Pancreat Surg; 2009; 16(5):668-74. PubMed ID: 19412570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in K-ras and p53 gene mutations among pancreatic adenocarcinomas associated with regional environmental pollution.
    Soliman AS; Lo AC; Banerjee M; El-Ghawalby N; Khaled HM; Bayoumi S; Seifeldin IA; Abdel-Aziz A; Abbruzzese JL; Greenson JK; Hamilton SR
    Carcinogenesis; 2007 Aug; 28(8):1794-9. PubMed ID: 17575320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation.
    Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N
    J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and alteration of ras and p53 proteins in patients with lung carcinoma accompanied by idiopathic pulmonary fibrosis.
    Takahashi T; Munakata M; Ohtsuka Y; Nisihara H; Nasuhara Y; Kamachi-Satoh A; Dosaka-Akita H; Homma Y; Kawakami Y
    Cancer; 2002 Aug; 95(3):624-33. PubMed ID: 12209756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 gene mutation and p53 protein overexpression in a patient with simultaneous double cancer of the gallbladder and bile duct associated with pancreaticobiliary maljunction.
    Kasuya K; Nagakawa Y; Matsudo T; Ozawa T; Tsuchida A; Aoki T; Itoi T; Itokawa F
    J Hepatobiliary Pancreat Surg; 2009; 16(3):376-81. PubMed ID: 19183832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [K-ras mutations detection in paraaortic lymph nodes and its prognostic value after the surgical treatment of pancreas cancer].
    Agaev BA; Muslimov GF; Iagublu VSh; Babaeva NR
    Khirurgiia (Mosk); 2008; (9):64-9. PubMed ID: 18833187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA.
    Marchese R; Muleti A; Pasqualetti P; Bucci B; Stigliano A; Brunetti E; De Angelis M; Mazzoni G; Tocchi A; Brozzetti S
    Pancreas; 2006 Mar; 32(2):171-7. PubMed ID: 16552337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
    Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
    Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of K-ras mutations in the plasma DNA of pancreatic cancer patients.
    Uemura T; Hibi K; Kaneko T; Takeda S; Inoue S; Okochi O; Nagasaka T; Nakao A
    J Gastroenterol; 2004 Jan; 39(1):56-60. PubMed ID: 14767735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.
    Pavelić K; Dedivitis RA; Kapitanović S; Cacev T; Guirado CR; Danić D; Radosević S; Brkić K; Pegan B; Krizanac S; Kusić Z; Spaventi S; Bura M
    Mutat Res; 2006 Jul; 599(1-2):45-57. PubMed ID: 16698048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
    Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
    Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic alterations in adenoma-carcinoma sequencing of intraductal papillary-mucinous neoplasm of the pancreas.
    Nakata B; Yashiro M; Nishioka N; Aya M; Yamada S; Takenaka C; Ohira M; Ishikawa T; Nishino H; Wakasa K; Hirakawa K
    Int J Oncol; 2002 Nov; 21(5):1067-72. PubMed ID: 12370756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of detection of K-ras gene mutations and CA19-9 in serum for diagnosis of pancreatic carcinoma].
    Zhang Y; Ji SR; Feng DX; Ji J; Han TQ
    Ai Zheng; 2003 Mar; 22(3):295-7. PubMed ID: 12654190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.